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INTRODUCTION
Mitochondria dysfunction (Leuner et al.,
2012) and blood-brain barrier (BBB)
impairment (Deane and Zlokovic, 2007)
are novel researches and insights into the
pathogenesis of Alzheimer’s Disease (AD),
which could lead to classification of AD as
a neurovascular disease. Furthermore, on
the basis of AD there could be an impair-
ment of neurons response to insulin,
that explain the increasing of cerebral
blood glycaemia, due to the lowering of
insulin receptors and/or of their response.
One of the Authors gathered interest-
ing data, due to the fact that there is
notoriously an association between high
serum cholesterol, raised blood pressure
and, finally, insulin-resistance, accord-
ing with Quantum Biophysical Semeiotics
(QBS) theory (Stagnaro and Stagnaro-
Neri, 2004b).
QBS theory offers an approach “as a
whole” of the patho-physiology of inher-
ited mitochondrial neurodegenerative
diseases, as well as that of AD in its various
forms, characterized by an Inherited Real
Risk (IRR) of Brain Disorders (Stagnaro
and Caramel, 2011). In the frame of
QBS theory, the combination of Clinical
Microangiology and “Angiobiopathy” the-
ory (Stagnaro, 2009a), allows to merge
the hypothesis of AD as neurological
microvascular—based disease and the
researches focused on mitochondrial
dysfunction according to the inherited
genetic causes of this neurodegenerative
pathology, i.e., the congenital alteration
of mit-DNA in related neuronal cells.
QBS is a new discipline in medical field
and an extension of the classical medical
semeiotics with the support of quantum
and complexity theories. It is a scientific
trans-disciplinary approach that is based
on the “Congenital Acidosic Enzyme-
Metabolic Histangiopathy” (CAEMH)
(Stagnaro and Stagnaro-Neri, 1987), a
unique mitochondrial cytopathy that is
present at birth and subject to med-
ical therapy. The presence of intense
CAEMH in a well-defined area (i.e.,
myocardium) is due to gene mutations
in both n-DNA and mit-DNA. This is
the basis for one or more QBS constitu-
tions (Stagnaro and Stagnaro-Neri, 2004a)
which could bring about their respec-
tive IRR (Stagnaro and Caramel, 2012,
2013a,b).
The QBS method allows the clinical
and pre-clinical diagnosis of the most
severe diseases such as the IRR of brain
disorders (Stagnaro and Stagnaro-Neri,
2004b; Stagnaro, 2009a; Stagnaro and
Caramel, 2011); this is achieved in the
easier way through the auscultatory per-
cussion of the stomach (Stagnaro, 1985a,b,
1986). Made with the aid of gastric
aspecific reflex, this diagnosis is consis-
tent and dually reflects the informative
nature and quality of parameters collected
by QBS microcirculatory investigations.
The patho-physiology of QBS reflexes
is based upon local microvascular con-
ditions. In case of genetic alteration of
both DNAs, intense CAEMH, and IRR
of Brain Disorders there is a microcir-
culatory remodeling, especially intense
under environmental risk factors, due
to vasomotility and vasomotion impair-
ment (e.g., functional imperfection) and
structural obstructions, i.e., patholog-
ical Endoarteriolar Blocking Devices
(EBDs) and Arteriovenous Anastomosis
(AVA) (Stagnaro, 2009c). According to
QBS, most of these inherited impair-
ments are already present, in a similar
form, in micro-vascular neurobiolog-
ical systems and clinically observable
since birth, through ureteral reflexes
diagnosis. Briefly, in healthy, from the
microcirculatory point of view, during
stress test both vasomotility (chaotic-
deterministic oscillations of arterioles)
and vasomotility (chaotic deterministic
fluctuations of nutritional capillaries and
post-capillary venules) are maximally
activated (Stagnaro and Stagnaro-Neri,
2004b; Stagnaro, 2009a; Stagnaro and
Caramel, 2011), particularly in hippocam-
pus, pre- frontal and parietal cerebral
regions. On the contrary, in individu-
als with a family history positive for AD
and, of course, in patients in the first
stages of AD, under identical conditions a
dissociated form of microcirculatory acti-
vation appears, characterized by increased
vasomotility and decreased vasomotion.
The flow- and flux-motion in the cere-
bral microcirculatory bed appears to be
clearly decreased, due to the dangerous
phenomenon of the so-called “micro-
circulatory blood-flow centralization.”
Unfortunately, it is generally admitted
that AD diagnosis, particularly in initial
stages, is very difficult. The test of acute
pick of insulin secretion (Stagnaro-Neri
and Stagnaro, 1997) proves to be reli-
able in bed-side recognizing this (and
other numerous) disorder, even in its first
stage. Although insulin is not necessary
in the glucose utilizations of cerebral
neurons, surely in both cerebral cor-
tex and hippocampus there is a large
amount of insulin receptors (Craft, 1996).
In initial stages of the disease a scarce
glucose metabolism in cerebral tissue
appears: venous glucose level seems to
be slightly decreased (Stagnaro, 2009b).
The authors, in addition, showed that
O2 consumption is unchanged, due to
the fact that the neurons utilize other
“endocellular” substances rather than glu-
cose, probably causing neurons death
(Stagnaro and Stagnaro-Neri, 1987,
2004a,b; Stagnaro, 2009a; Stagnaro and
Caramel, 2011).
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In summary, in the complex diffi-
cult understood pathophysiology of AD a
fault response of cerebral insulin receptors
exists, while the hormone acts likely as a
growth factor. From these work hypoth-
esis, in a previous clinical research we
observed that, in healthy, the acute pick
of insulin secretion (Stagnaro-Neri and
Stagnaro, 1997) activates the microcir-
culation in all biological systems, while
in patients at IRR of AD and, natu-
rally, in patients involved by the dis-
ease, even in early stage, microcirculatory
activation is totally absent. Interestingly,
in no other cerebral disorders, includ-
ing cerebral arteriosclerosis, it has been
observed the absence of insulin-receptors
response. From the above remarks, our
research is consistent with other authors’
theory (Koudinov and Koudinov, 2001),
according to which cholesterol is impli-
cated in AD, due to the fact that accurate
neuronal cholesterol dynamics is criti-
cal for the synaptic plasticity and neural
degeneration. These data also imply the
link between neuronal lipid metabolism
and tau and amyloid beta neurochem-
istry and propose that the classical AD
brain lesions are functional consequences
of the neuronal cholesterol and possibly
phospholipids biological mis-regulation.
In addition, insulin-receptors are less
responsive to insulin under such circum-
stances, as shown previous. The central
role of QBS Constitutions and of the
IRR of brain disorders in aging peo-
ple disease occurrence is due also espe-
cially if Co Q10 deficiency is present.
QBS diagnosis of Co Q10 deficiency
syndrome, at bed-side, described ear-
lier (Stagnaro-Neri and Stagnaro, 1990),
could be very helpful in risk stratifi-
cation to predict functional decline in
older adults. Doctors can clinically rec-
ognize, with the aid of a stethoscope,
subjects involved by ubidecarenone defi-
ciency, even initial and symptomless, caus-
ing damage of tissues due to the increase
levels of free radical (Stagnaro-Neri and
Stagnaro, 1992). Such a diagnosis, made
clinically for the first time, proved to be
really efficacious and reliable in avoid-
ing dangerous administration of statins
to individuals without clinical symptoma-
tology, even involved by ubidecarenone
deficiency, notoriously worsened by anti-
cholesteremic drugs.
INHERITED REAL RISK OF
ALZHEIMER’S DISEASE: BEDSIDE
DIAGNOSIS
QBS is able to make IRR of brain disor-
ders diagnosis in particular through the
auscultatory percussion of the Stomach,
easier to understand and apply in the daily
practice, i.e., revealing if any subject, from
the moment of birth, is at risk of brain
disorders.
Among the several QBS signs, one of
these is the simultaneous brain gastric
aspecific reflex (GAR) in case of “intense”
digital pressure on brain’s trigger points.
This reflex is related with the non-local
quantum behavior of biological systems
(Stagnaro and Caramel, 2011). In health,
“intense” digital pressure on brain’s trig-
ger points (any point of the cranium),
does not provoke simultaneously GAR
(the reflex appears just after 16 s due to
physiological tissue acidosis), thus there
is not IRR of brain disorders (negative
Marchionni’s sign): this is the physiologi-
cal state (Stagnaro, 2009a).
If the stomach moves simultaneously,
dilating for at least 1 cm or more, then
there is IRR of brain disorders or overt
brain disease (if the stomach dilates more
than 1.5 cm) termed positive Marchionni’s
sign. If there is a IRR of brain disorders,
in order to discover of which kind of cere-
bral disease an individual is at risk, the
doctors must refine the diagnosis mak-
ing an investigation more focused on the
correct localization of the underlying clin-
ical neurological disorder. This is achieved
through QBS assessment of the related
specific signs. In fact, this is an aspe-
cific sign, but it becomes specific if the
microcirculatory remodeling (Stagnaro
and Stagnaro-Neri, 1987; Stagnaro, 2009a;
Stagnaro and Caramel, 2011) is present
in the typical areas of the related brain
disorder, i.e., pre-frontal areas and limbic
region, typical areas of AD. There are two
main QBS tests able to verify if the IRR of
brain disorders is related to AD: the test
of insulin secretion acute peak (Stagnaro-
Neri and Stagnaro, 1997) and the test of
microcirculatory activation of the brain.
In order to apply the insulin secretion
test, physicians, after assessing the basal
value parameters of the above-described
reflexes, immediately thereafter stimu-
lates by lasting pinching the skin of VI
thoracic dermathomere for 15 s, repeating
the evaluation of the identical reflexes: in
both health and patients involved by senile
dementia, vascular in origin or mixed,
the test improves “always” the numerous
parameters mentioned above, although in
different manner. For instance, in case of
“initial” and asymptomatic senile decay,
the latency time of the brain GAR increases
from 5–6 s (basal value is 6 s) to 6–7 s
(basal value is 8 s). On the contrary, in
case of AD, starting from the very ini-
tial stage without clinical symptomatology,
over years or decades, the acute pick of
insulin secretion does not improve at all
the above-mentioned parameters values of
reflexes, which are identical to those of
basal assessment.
In case of intense pressure on brain’s
trigger points related to AD (limbic region,
pre-frontal area, parietal and occipital cor-
tex) if the reflex appear simultaneously
there is an IRR of brain disorder linked
to AD, but only if the intensity of the
reflex is more than 1 cm: positive spe-
cific QBS sign due to the fact that the
remodeling is present in the typical areas
of AD.
INHERITED REAL RISK OF
ALZHEIMER’S DISEASE: PRIMARY
AND PRE-PRIMARY PREVENTION
QBS tools are not only useful for diag-
nostic purposes, but also for therapeutic
advices, because they are able to mea-
sure the microcirculatory activity before
and after each preventive therapy’s treat-
ment, in order to understand the effec-
tiveness of remedies. Some years ago, one
of the authors (Stagnaro and Stagnaro-
Neri, 2004a) let us an open question: are
QBS Constitutions and IRR of degenera-
tive pathologies reversible?
Through a proper prevention treat-
ment termed “type A” or “green” therapy,
i.e., modified Mediterranean diet, CoQ10,
conjugated-melatonin, carnitine, a genetic
reversibility for future generations is pos-
sible (Stagnaro and Caramel, 2013c), but
this could not be enough for the current
generations, especially under environmen-
tal negative conditions. The green therapy
stimulates the activity of mitochondria by
acting on metabolism, peptides’ net, but
also improving, normalizing mitochon-
drial and tissue oxygenation, expression
of the normal operation of mitochon-
drial oxidative phosphorylation. Indeed,
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the mitochondrial functional cytopathy
above mentioned (CAEMH) is the con-
ditio sine qua non of more frequent and
severe human disease and not. By this
way tissue oxygenation and mitochondrial
activity are improved, mitochondria are
running well, but it remains the genetic
alteration of mit-DNA: CAEMH, QBS
Constitutions and IRR of diseases are still
positive, but the IRR becomes “residual.”
This means that a continuative “type A”
therapy averts the risk that the disease can
emerge, despite the genetic problem is not
yet healed.
QBS method allows an efficient pre-
primary prevention with recursive effects
able to reverse the genetic alteration of
mit-DNA and the mitochondrial cytopa-
thy at the base also of neurodegener-
ative pathologies such as AD. This is
possible under a Type B or blue ther-
apy. In particular, we have successfully
used a Quantum Therapy (Stagnaro and
Caramel, 2013c,d) for the pre-primary
prevention of cancer, Type 2 Diabetes
Mellitus, osteoporosis, Coronary Artery
Disease andAmyotrophic Lateral Sclerosis.
“We are not going to regenerate new neu-
rons but we will stop the decline,” McKew
hopes. Well, Quantum Therapy central
action mechanism consists in remodel-
ing neurological centers, when heritably
altered.
CONCLUSIONS
Alzheimer Disease is not reversible by
medical treatments, and the current
research is concentrated just on genetic
and histological clinical tests. QBS can
provide for such disorder a biological
preventive evaluation, because biological
system functional modification parallels
gene mutation. Furthermore QBS is able
to make a diagnosis of AD not only at the
first very initial stages, usually very dif-
ficult to do, but even many years before
that such disease could appear, allowing
so an efficacious primary prevention,
specially prescribing proper preventive
treatments, already tested to be really effi-
cacious in healing the IRR of other severe
degenerative diseases.
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